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A B S T R A C T  
Diabetes is a chronic disorder of carbohydrate, fat and protein metabolism 
characterized by increased fasting and post prandial blood sugar levels. The 
global prevalence of diabetes is estimated to increase, from 4% in 1995 to 
5.4% by the year 2025. WHO has predicted that the major burden will occur in 
developing countries? Since ancient times, plants have been an exemplary 
source of medicine. Ayurveda and other Indian literature mention the use of 
plants in treatment of various human ailments. India has about 45000 plant 
species and among them, several thousands have been claimed to possess 
medicinal properties. Research conducted in last few decades on plants 
mentioned in ancient literature or used traditionally for diabetes has shown anti-
diabetic property. In the last few years there has been an exponential growth in 
the field of herbal medicine and these drugs are gaining popularity both in 
developing and developed countries because of their natural origin and less 
side effects. The present paper reviews some of such plants and their products 
(active, natural principles and crude extracts) that have been mentioned/used 
in the Indian traditional system of medicine and have shown experimental or 
clinical anti-diabetic activity. We believe that the list of medicinally important 
families and plants presented in this review is useful to researchers, as well as 
practitioners. 
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Introduction 
In the last few years there has been an exponential 
growth in the field of herbal medicine and these drugs 
are gaining popularity both in developing and developed 
countries because of their natural origin and less side 
effects. Many traditional medicines in use are derived 
from medicinal plants, minerals and organic matter [1]. 
A number of medicinal plants, traditionally used for over 
1000 years named rasayana are present in herbal 
preparations of Indian traditional health care systems 
[2]. In Indian systems of medicine most practitioners 
formulate and dispense their own recipes [3]. The World 
Health Organization (WHO) has listed 21,000 plants, 
which are used for medicinal purposes around the 
world. Among these 2500 species are in India, out of 
which 150 species are used commercially on a fairly 
large scale. India is the largest producer of medicinal 
herbs and is called as botanical garden of the world [3]. 
Studies conducted in India in the last decade have 
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highlighted that not only is the prevalence of diabetes 
high but also that it is increasing rapidly in the urban 
population [4]. It is estimated that there are 
approximately 33 million adults with diabetes in India. 
This number is likely to increase to 57.2 million by the 
year 2025. Diabetes mellitus is a complex metabolic 
disorder resulting from either insulin insufficiency or 
insulin dysfunction. Type I diabetes (insulin dependent) 
is caused due to insulin insufficiency because of lack of 
functional beta cells. Patients suffering from this are 
therefore totally dependent on exogenous source of 
insulin while patients suffering from Type II diabetes 
(insulin independent) are unable to respond to insulin 
and can be treated with dietary changes, exercise and 
medication. Type II diabetes is the more common form 
of diabetes constituting 90% of the diabetic population. 
Symptoms for both diabetic conditions may include: (i) 
high levels of sugar in the blood; (ii) unusual thirst; (iii) 
frequent urination; (iv) extreme hunger and loss of 
weight; (v) blurred vision; (vi) nausea and vomiting; (vii) 
extreme weakness and tiredness; (viii) irritability, mood 
changes etc. Though pathophysiology of diabetes 
remains to be fully understood, experimental evidences 
suggest the involvement of free radicals in the 
pathogenesis of diabetes [5] and more importantly in 
the development of diabetic complications [6–8]. Free 
radicals are capable of damaging cellular molecules, 
DNA, proteins and lipids leading to altered cellular 
functions. Many recent studies reveal that antioxidants 
capable of neutralizing free radicals are effective in 
preventing experimentally induced diabetes in animal 
models [9, 10] as well as reducing the severity of 
diabetic complications [8].  
 
For the development of diabetic complications, the 
abnormalities produced in lipids and proteins are the 
major etiologic factors. In diabetic patients, extra-
cellular and long lived proteins, such as elastin, laminin, 
collagen are the major targets of free radicals. These 
proteins are modified to form glycoproteins due to 
hyperglycemia. The modification of these proteins 
present in tissues such as lens, vascular wall and 
basement membranes are associated with the 
development of complications of diabetes such as 
cataracts, microangiopathy, atherosclerosis and 
nephropathy [11]. During diabetes, lipoproteins are 
oxidized by free radicals. There are also multiple 
abnormalities of lipoprotein metabolism in very low 
density lipoprotein (VLDL), low density lipoprotein 
(LDL), and high density lipoprotein (HDL) in diabetes. 
Lipid peroxidation is enhanced due to increased 
oxidative stress in diabetic condition. Apart from this, 
advanced glycation end products (AGEs) are formed by 
non-enzymatic glycosylation of proteins. AGEs tend to 
accumulate on long-lived molecules in tissues and 
generate abnormalities in cell and tissue functions [12, 
13]. In addition, AGEs also contribute to increased 
vascular permeability in both micro and macrovascular 
structures by binding to specific macrophage receptors. 
This results in formation of free radicals and endothelial 
dysfunction. AGEs are also formed on nucleic acids and 
histones and may cause mutations and altered gene 
expression. 
 
As diabetes is a multifactorial disease leading to several 
complications, and therefore demands a multiple 
therapeutic approach. Patients of diabetes either do not 
make enough insulin or their cells do not respond to 
insulin. In case of total lack of insulin, patients are given 
insulin injections. Whereas in case of those where cells 
do not respond to insulin many different drugs are 
developed taking into consideration possible 
disturbances in carbohydrate-metabolism. For example, 
to manage post-prandial hyper-glycaemia at digestive 
level, glucosidase inhibitors such as acarbose, miglitol 
and voglibose are used. These inhibit degradation of 
carbohydrates thereby reducing the glucose absorption 
by the cells. To enhance glucose uptake by peripheral 
cells biguanide such as metphormine is used. 
Sulphonylureas like glibenclamide is insulinotropic and 
works as secretogogue for pancreatic cells. Although 
several therapies are in use for treatment, there are 
certain limitations due to high cost and side effects such 
as development of hypoglycemia, weight gain, 
gastrointestinal disturbances, liver toxicity etc [14]. 
Based on recent advances and involvement of oxidative 
stress in complicating diabetes mellitus, efforts are on to 
find suitable antidiabetic and antioxidant therapy. 
 
Material and methods 
Role of phytomedicine in diabetes 
Phytomedicine are being looked up once again for the 
treatment of diabetes. Many conventional drugs have 
been derived from prototypic molecules in medicinal 
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plants. Metformin exemplifies an efficacious oral 
glucose-lowering agent. Its development was based on 
the use of Galega officinalis to treat diabetes. Galega 
officinalis is rich in guanidine, the hypoglycemic 
component. Because guanidine is too toxic for clinical 
use, the alkyl biguanides synthalin A and synthalin B 
were introduced as oral anti-diabetic agents in Europe 
in the 1920s but were discontinued after insulin became 
more widely available. However, experience with 
guanidine and biguanides prompted the development of 
metformin. To date, over 400 traditional plant 
treatments for diabetes have been reported, although 
only a small number of these have received scientific 
and medical evaluation to assess their efficacy. The 
hypoglycemic effect of some herbal extracts has been 
confirmed in human and animal models of type 2 
diabetes. The World Health Organization Expert 
Committee on diabetes has recommended that 
traditional medicinal herbs be further investigated. Major 
hindrance in amalgamation of herbal medicine in 
modern medical practices is lack of scientific and 
clinical data proving their efficacy and safety. There is a 
need for conducting clinical research in herbal drugs, 
developing simple bioassays for biological 
standardization, pharmacological and toxicological 
evaluation, and developing various animal models for 
toxicity and safety evaluation. It is also important to 
establish the active component/s from these plant 
extracts. 
 
Table 1 - Some Important Examples of Potential Anti Diabetic Phytomedicine.  
Botanical Name Family Vernacular Part(s) Ethnobotanical Usage 
Acacia arabica (Lam.) Willd. Mimosaceae Karuvaelai S Seeds hypoglycemic 
Aegle marmelos (L.) Corr. 
Rutaceae Vilvam L Leaf powder with cow's 
milk is taken orally. 
Allium cepa Linn. 
Alliaceae Vengayam  B Leaf juice with honey or 
milk and taken orally. 
Allium sativum Linn. 
Alliaceae Pundu B Leaf, bulb antidiabetic 
taken orally. 
Andrographis lineata Wall. 
ex Nees. 
Acanthaceae Siriyanangai L Leaf powder mixed with 
cow's milk is taken  
Azadirachta indica A. Juss. Meliaceae Vembu L Leaves anti diabetic.  
Bombax ceiba L 
Bombacaceae  Elavampanchu S Seed powder with 
goat’s milk is taken 
orally. 
Brassica juncea (Linn.) 
Czern. & Coss. 
Bracecaceae Kadugu S Seed powder with milk 
is taken orally 
Cajanus cajan (Linn.) Millsp. 
Fabaceae Thuvarai S Seeds cooked and 
taken along with food. 
Catharanthus roseus L. (G) 
Don. 
Apocyanaceae  Nityakalyani  WP  Flower decoction taken 
orally. 
Coccinia indica W & A 
Cucurbitaceae  Kovai F Leaf / Fruit decoction is 
taken topically.  
Cuminum cyminum Linn. Apiaceae  Cheerakam   S  Fruit soaked in water 
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and taken orally. 
Erythrina indica Lam.  
Fabaceae Mulmurungai L Leaves consumed to 
treat diabetics. 
Euphorbia antiquorum Linn. 
Euphorbiaceae Chzathura kalli L Leaves /fruits 
consumed to treat 
diabetics. 
Ficus benghalensis Linn. 
Moraceae Alamaram F Fruits taken to treat 
diabetics. 
Gymnema sylvestre R.Br. 
Apocyanaceae  Sakkaraikolli L  Leaf made to juice and 
taken orally. 
Hibiscus rosa-sinesis Linn. 
Malvaceae  Sembaruthi L  Tender fresh leaves 
used to cure diabetes. 
Ipomoea batatas (Linn.) 
Convolvulaceae  Sakkaraivalli T  Leaf juice is taken to 
treat diabetics 
Jatropha glandulifera Rox. 
Euphorbiaceae Adalai chedi T Tubers boiled and 
taken to treat diabetics. 
Lantana camara Linn. 
Verbenaceae Unni chedi L/F Leaf and fruits 
consumed raw - treat 
diabetics. 
Mangifera indica L. 
Anacardiaceae  Ma S Dry kernel powder in 
cow’s milk.   
Momordica charantia L. 
Cucurbitaceae  Pavai  F  Fruit juice is taken to 
treat diabetics. 
Murraya koeingii (L.) 
Spreng. 
Rutaceae  Karuvepalai  L  Leaf juice is taken to 
treat diabetics. 
Murraya koeingii (L.) 
Spreng. 
Rutaceae  Karuvepalai  L  Leaf juice is taken to 
treat diabetics. 
Nelumbo nucifera Gaertn. 
Nymphiaceae  Alli  F  Flowers made to juice 
and taken orally. 
Ocimum santum L. 
Lamiaceae Thulasi L Leaf powder in     
honey taken oral.  
Punica granatum L. 
Punicaceae Madulai F Fruit used to treat 
diabetics.  
Syzygium cumini (L.) Skeels 
Myrtaceae  Naval  S Seeds powder reduce 
blood sugar/ diabetics  
Trigonella foenum-graecum 
L. 
Fabaceae  Vendhyem  S Seed soaked in water 
used to treat diabetics 
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Table 2- The list of potential hypoglycemic plant families, scientific name of the plant, route of administration ,animal 
used, dose, active ingredient and their effects. 
Biological Family 
Route of 
administration 
Animal used Dose Active ingradient Effect 
Acanthaceae 
(Asteracantha 
longifolia) 
Oral alloxan-induced 
diabetic 
rabbits 
(20 g/kg of 
starting 
material) 
 improve glucose 
tolerance in 
healthy human 
subjects and 
diabetic 
patients. 
Amaranthaceae 
(Achyranthes 
aspera) 
Oral alloxan-induced 
diabetic 
rabbits 
2, 3, and 4 
g/kg 
calcium, zinc, 
magnesium, 
manganese and 
copper  
significant dose-
related 
hypoglycaemic 
effect 
Anacardiaceae 
(Mangifera indica) 
Oral Wiztar rats 150mg/kg Mangiferin, 
sucrose 
Xylose, flavonidal 
tannins 
hypoglycaemic 
action due to a 
reduction in the 
intestinal 
absorption of 
glucose. 
Apiaceae 
(Daucus carota) 
Oral Male Swiss mice 200mg/kg Pectin,carotin, 
extractine gluten, 
albumen, volatile 
oil 
improve the 
glucose 
tolerance. 
Apocynaceae 
(Rhazya stricta ) 
Oral streptozotocin-
diabetic 
rats. 
0.5, 
2.0 and 
4.0 g/kg 
Alkaloids, 
flavonoids 
glycaemia 
was reduced by 
approximately 6, 
8 and 30 %, 
respectively. 
Araliaceae 
(Ginseng Radix) 
i.v adrenaline-
induced 
hyperglycaemic 
mice 
100 mg/kg Ginseng 
polypeptides 
lowered blood 
glucose level in 
diabetic 
animals. 
Chenopodiaceae 
(Beta vulgaris 
var.Cicla L.) 
Oral alloxanised 
diabetic rats 
200mg/kg Betavulgarosides 
I, II, III, IV, VI, VII, 
VIII 
oleanolic acid 
oligoglycosides  
 
inhibited the 
increase in the 
nonenzymatic 
glycosylation of 
skin proteins 
and blood 
glucose.  
 
 
Recent research and reviews 
A number of reviews have been published in the last 
three decades on plants screened for hypoglycemic 
activity in India [15-31] and elsewhere[27-29]. 
Very recently, two exhaustive reviews have been 
published based on global literature survey on 150 
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plants[28] and 343 plants[29] from different parts of the 
world. some plants like 
Allium cepa (Onion, piyaj), Allium sativum (garlic, 
lasun), Syzygium cumini (Syn. Eugenia jambolana; 
(black plum; jamun), Momordica charantia (bitter 
gourd; karela) Gymema sylvestre (Gurmar), 
Pterocarpus marsupium (Vijay-) sar) etc. have 
attracted more attention of the scientists as well as 
laymen, in recent years. Only a few of phytomedicine 
will be discussed here, in" some detail.(Table no1& 2) 
In most animal studies, water extracts or alcoholic 
extracts of the plants have been screened. In a few 
studies, the active principles of plants have been 
investigated for hypoglycemic activity. In a systematic 
screening programme of plants available in India over 
several decades, October, 1989 the Central Drug 
Research Institute (CDRI), Lucknow (India), reported 
positive hypoglycemic activity in only 11 plants[56], 
none of which was considered encouraging enough for 
being taken up for further studies. Among the major 
chemical constituents of plants credited with 
hypoglycemic action are glycosides, alkaloids, glycans, 
triterpenes, mucilages, polysaccharides, oils, vitamins, 
saponins, glycoproteins, peptides, amino acids & 
proteins. Reports on as many as 20 plant mucilages 
showing hypoglycaemic activity have been reviewed 
recently[28]. Among these, mucilages isolated from 
Malavaceous plants which show hypoglycemic activity 
have been found to have highly interesting chemical 
structure relating to a trisaccharide structural unit 
which offer interesting leads on structure-activity 
relationship. Pharmacological screening for 
hypoglycemic activity has been done using various 
animal models like normal, fasting rats & rabbits; 
alloxan-treated rabbits; hyperglyceraia induced in rats 
by adrenaline, corticoropin, somatotropin as also by 
streptozotocin and by pancreatectomy. On plants like 
Momordica charantia and Pterocarpus mar sup um, 
some contradictory results have been reported by 
different groups of Indian workers. M. charantia has 
revealed hypoglycemic activity in most studies. Thus, 
the fruit of this plant showed hypoglycemic effect in 
normal & alloxan-induced diabetic rabbits[38], while M. 
charantia seeds proved hypoglycemic in 
streptozotocin-induced diabetes in rabbits in normal 
rabbits[41], in normal & alloxan diabetic dogs[40], in 
hyperglycemia induced by anterior pituitary extract in 
rats[33].In other studies on rabbits, M. charantia juice 
showed only a mild hypoglycemic effect in normal & 
alloxan diabetic animals, while proving to be toxic at 10 
ml/kg dose[39]. It showed no effect on normal rabbits 
either on acute or chronic administration[57]. Clear cut 
data on the actual chemical constituents of bitter gourd 
which can be held responsible for its hypoglycemic 
activity arelacking, in spite of a number of reports on 
charantin (the non-nitrogenous neutral principle) and 
the polypeptide-p[42] or plant (P)- insulin [43,55] 
isolated from this plant. Another plant well reputed in 
Ayurvedic medicine as an anti-diabetic drug and which 
has also shown considerable promise in initial 
pharmacological studies is Pterocarpus marsupium. 
After sporadic studies on various extracts of the plant 
(between 1959 and 1971) by different group of 
authors,[34,37,44,45] a series of investigations on rats 
done at Banaras Hindu University, Varanasi, claimed a 
novel antidiabetic mechanism of action of the flavonoid 
isolated from P. marsupium viz. (—) epicatechin- The 
flavonid (isolated from the plant), as also its synthetic 
counterpart, were claimed to regenerate the j8-cells of 
the islets of pancreas in alloxon diabetic rats[33,49,52]. 
These startling results attributed to (—) epicatechin 
were, however, not confirmed by other workers from 
different parts of the world [58-60].  
 
This serves as a familiar example of a few over-
enthusiastic scientists jumping to premature 
conclusions on the identity of 'active principles' as well 
as a novel mode of action of plant drugs without 
confirmatory evidence. Despite such setbacks, as the 
October, 1989 crude, extract of the plant has shown a 
hypoglycemic effect consistently and the plant 
continues to be used in clinical practice by Ayurvedic 
physicians (especially in North India) for the 
management of diabetes, further studies, are called for 
on this plant. Gymnema sylvestre is yet another plant 
reputed specially in South India for its use as an 
antidiabetic drug. Adrenaline-induced hyperglycemia in 
rats was countered by injection of the leaf extract [47]. 
Orally, the leaves significantly reduced the 
hyperglycemia induced in rats by anterior pituitary 
extract[46]. In alloxan diabetic rabbits, the leaf extract 
of the plant reduced the blood sugar level and also 
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reversed the hepatic changes produced by 
hyperglycemia [48,51]. The alcohol-water extract of G. 
sylvestre restored the elevated protein-bound 
polysaccharide components & glycosaminoglycans in 
serum & tissues of alloxan diabetic rats, and it was 
suggested that the plant apparently restores the 
synthesis of sulfated glyosaminolycans and thereby 
could be of possible assistance in preventing vascular 
complications of diabetes [36]. The seeds of Syzygium 
cumini are used by the Ayurvedic physicians (and also 
in Indian folklore) in the treatment of diabetes mellitus. 
The hypoglycaemic activity of the seeds has been 
studied by several workers in animal models 
[32,35,54]. In alloxan diabetic rats, S. cumini seed 
extract led to a decrease in the levels of blood glucose, 
urea and serum triglyceride levels [50,53]. The 
botanical identity of certain plants used by Ayurvedic 
clinicians is known to be controvertial. One such 
example is of the drug 'Saptarangi' famed in Ayurveda 
as an antidiabetic agent. This plant was screened for 
hypoglycaemic activity under the Composite Drug 
Research Scheme (CDRS) of the Indian Council of 
Medical Research during 1965-69. In the initial part of 
the study, the drug 'Saptarangi' was botanically 
identified as Caeseria esculenta. However, the 
commercially available Saptarangi was subsequently 
correctly identified as Salacia prenoides (yellow 
variety) and Salacia macrosperma (brown variety). S. 
prenoides (aqueous extract) evinced hypoglycemic 
activity comparable to tolbutamide in glucose tolerance 
tests in male rabbits [61]. This experience illustrates 
and emphasizes the vital need for authentic botanical 
identification of the plants before embarking on 
chemical and biological studies. Some known 
antidiabetic potential phytomedicine are listed in Table 
no 2 and is best used only as a preliminary screening 
of potential antidiabetic plants, not as a definitive or 
complete list of hypoglycemic plants.  
 
Sketch map of the area of most of the drugs discussed. 
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Percentage distribution analysis of anti-diabetic remedies obtained from different plant parts. 
Conclusion 
Diabetes is a chronic disorder of carbohydrate, fat and 
protein metabolism characterized by increased fasting 
and post prandial blood sugar levels. The global 
prevalence of diabetes is estimated to increase, from 
4% in 1995 to 5.4% by the year 2025. WHO has 
predicted that the major burden will occur in 
developing countries. Studies conducted in India in the 
last decade have highlighted that not only is the 
prevalence of diabetes high but also that it is 
increasing rapidly in the urban population. It is 
estimated that there are approximately 33 million 
adults with diabetes in India. This number is likely to 
increase to 57.2 million by the year 2025. 
Phytomedicine are being looked up once again for the 
treatment of diabetes. Many conventional drugs have 
been derived from prototypic molecules in medicinal 
plants. We believe that the list of medicinally important 
families and plants  presented in this review is useful to 
researchers, as well as practitioners. 
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